Microbix Introduces Viral Transport Medium

Ontario Industry Updates
Written By Maura Campbell
Micobix.png

Microbix Biosystems Inc., a life sciences innovator and exporter, announced the commercial availability of its viral transport medium (VTM) to support Canadian RT-PCR (molecular) testing for the virus causing COVID-19 disease. Microbix has created a secure and locally-based supply of high-quality VTM and has begun VTM production at 50,000 vials per week using semi-automated methods and is targeting more-automated production of over 400,000 vials per week by the end of its fiscal 2021.

Maura Campbell
Previous

Notch Therapeutics Closes $85 Million Series A Financing
Next

Richardson Wealth and Bloom Burton & Co. Announce Strategic Alliance to Expand Wealth Solutions in Healthcare Sector